## Abstract Enzyme immunoassay (EIA) and radioimmunoassay (RIA) for the detection of antibody to hepatitis B core antigen (anti‐HBc) were compared using serum specimens from Alaska Natives screened during a hepatitis B control program that were initially positive by EIA for only anti‐HBc. Of 36 spe
Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population
✍ Scribed by Dr. A. C. M. Kroes; W. G. V. Quint; R. A. Heijtink
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 454 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Serum samples, which were found positive for anti‐HBc and negative for HBsAg and anti‐HBs during routine testing with Abbott enzyme immunoassays (EIA), were collected prospectively. The samples were obtained from patients with a high risk of hepatitis B. Further analysis was carried out using radioimmunoassays and tests for additional markers of hepatitis B. 84 of the 203 initially collected samples (41.4%) were found positive for anti‐HBs by RIA. Of the 119 samples negative for anti‐HBs by RIA, 103 were available for further investigation, and 35 (34.0%) of these were negative for anti‐HBc by RIA. This indicates that low sensitivity of the anti‐HBs EIA and non‐specificity of the anti‐HBc EIA may account for about 60% of the cases presenting with isolated anti‐HBc at initial testing. Fifty‐two samples positive for anti‐HBc by RIA, with isolated anti‐HBc confirmed after RIA testing for HBsAg and anti‐HBs, were examined further: anti‐HBe was detected in 16 sera, anti‐ HDV in one serum and HBV‐DNA in 5 sera by PCR. Additional testing of serum samples with isolated anti‐HBc is warranted.
📜 SIMILAR VOLUMES
To determine the current incidence of hepatitis B core antibody (anti-HBc) in a healthy blood donor population, 1,893 donors were screened for anti-HBc. Forty-one (2.16%) were found to be initially positive and 35 (1.85%) repeatably positive. Sera from the repeatably positive donors were further scr
IgM antibody against core antigen of the hepatitis B virus (anti-HBc IgM) was selectively determined by a new enzyme immunoassay (EIA). Microtiter plates were coated with anti-human micro chain immunoglobulin. On addition of serum IgM is bound by a factor of about 4,000 more than IgG. After removing
The objective of this study was to examine the seroprevalences of chronic infection with hepatitis B and C viruses and Helicobacter pylori in Matzu, a group of small islets with 5,566 civilian residents who have extremely high mortality from cancers of the stomach and liver. The standardized mortali